A model for priority setting of health technology assessment: the experience of AHP-TOPSIS combination approach
Published on: 11 April 2016
Skip to main content
DARU Journal of Pharmaceutical Sciences is an open access, peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment. The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications.
Published on: 11 April 2016
Letter to the Editor
Published on: 22 March 2016
Published on: 29 February 2016
Published on: 22 January 2014
Published on: 28 November 2012
Published on: 3 September 2012
Previous issues of DARU Journal of Pharmaceutical Sciences, published by Tehran University of Medical Sciences, can be found here. This includes all content from 1990-2011.
We would like to announce that the 2014 reviewer of the year is Dr Maryam Torshabi.
Pharm.D (2003, School of Pharmacy, Shahid Beheshti University of Medical Sciences), PhD. of Pharmaceutical Biotechnology (2010, School of Pharmacy, Tehran University of Medical Sciences), Assistant Professor (Department of Dental Biomaterials, School of Dentistry, Shahid Beheshti Univarsity of Medical Sciences, Since 2011)
Tehran University of Medical Sciences support DARU Journal of Pharmaceutical Sciences financially, resulting in a reduction in the article-processing charge (APC) that is payable upon editorial acceptance of an article. For articles submitted after 30 March 2015, the author-payable share of the APC is €600. Further details on the APC are available here.
Note for Iran-based authors
For authors based in Iran there is a special mechanism for covering the article-processing charge. Iran-based authors should enter the code DARU01 during the article submission process. If this code is used, Iran-based authors do not pay an APC to the publisher; instead, TUMS arranges payments with the publisher and will invoice the APC, payable in Iranian Rials, to the authors.
Mohammad Abdollahi (MA) acquired a PharmD in 1988 from the University of Tehran and then finished a PhD in Toxicology and Pharmacology in 1994 from the Tehran University of Medical Sciences. He gained a postdoctoral fellowship training at the University of Toronto in 2001. MA has obtained the honor of full professorship of Tehran University of Medical Sciences since 2002. MA has been dean of Department (Toxicology & Pharmacology) since 2005. Also MA has been the Secretary of National Board of Toxicology for 9 years and Chair of National Society of Toxicology for 8 years. So far, MA has contributed in authoring more than 600 papers in prestigious journals and authoring 48 book chapters and editing 11 books. MA has been listed among top scientists of ESI/ISI and OIC Member States. According to GS, current H-index, total citations, and i10 index of MA are 61, >14000, and 315, respectively. Besides having the position of DARU Editor-in-Chief (EiC). MA has cooperated with some key international organizations such as OPCW (Organization for Prohibition of Chemical Weapons) as a Scientific Advisory Board in the Netherlands, WHO (World Health Organization) as a Member of Guideline Developing Group for Prevention of Lead Poisoning in Switzerland, COPE (Committee on Publication Ethics) as Council Member in the UK, and IAS (Islamic-World Academy of Sciences) as a Fellow. In addition to more than ten prestigious national awards, MA has received the prominent award of IAS-COMSTECH in 2005 in the field of Pharmacology & Toxicology. The main research interests of MA are Mechanistic and Environmental Toxicology, Evidence-Based Medicine, and Pharmacology.